Skip to main content
Premium Trial:

Request an Annual Quote

Caliper, GE Healthcare

Premium
Caliper Life Sciences this week introduced the LabChip GXll microfluidic-based benchtop system for separations directed at protein and genomics applications.
 
The instrument has 96- and 384-well plate compatibility and the ability to select single wells at any location in a plate, Caliper said in a statement. It replaces the LabChip 90 system and provides consistent and precise analysis of both protein and nucleic acid samples.
 
The company also launched the LabChip GX system for genomics applications this week.
 

 
GE Healthcare this week launched version 7 of the ImageMaster 2D Platinum software package for analysis of 2D gel data.
 
New features include well-established methods for all 2D experiments, including single stain and 2D DIGE; easy import and image viewer functionality; and effective spot detection and matching solutions, GE said in a statement.
 
ImageMaster was developed by GE in collaboration with the Swiss Institute of Bioinformatics and GeneBio, and is powered by Melanie gel analysis software.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.